Chemokines and their receptors: predictors of the therapeutic potential of mesenchymal stromal cells
Nerea Cuesta‐Gomez(University of Alberta), John Campbell(Institute of Infection and Immunity)
Cited by 65
Related Papers
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial
|Nature Medicine|2025|47
Suspension culture improves iPSC expansion and pluripotency phenotype
|Stem Cell Research & Therapy|2023|39